Literature DB >> 8256661

Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture.

S J Hodges1, K Akesson, P Vergnaud, K Obrant, P D Delmas.   

Abstract

We measured the serum levels of phylloquinone (vitamin K1) and of the menaquinones, MK-7 and MK-8, in a group of 51 women with a mean age of 81 years who were studied within a few hours after a hip fracture. A group of 38 healthy age-matched women randomly chosen from the same population served as controls. Patients with hip fracture had a marked reduction in serum vitamin K1 (336 +/- 302 versus 585 +/- 490 pg/ml, p < 0.01), MK-7 (120 +/- 84 versus 226 +/- 178 pg/ml, p < 0.001), and MK-8 (89 +/- 113 versus 161 +/- 145 pg/ml, p < 0.01), and a large number had undetectable levels, especially of MK-8. Vitamin K levels were not correlated with the time elapsed after fracture or with serum cortisol or other biochemical variables. These data suggest that patients with hip fracture have vitamin K deficiency, an abnormality that could affect bone metabolism through an impairment of the gamma carboxylation of the gla-containing proteins of bone.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8256661     DOI: 10.1002/jbmr.5650081012

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  22 in total

Review 1.  A four-season molecule: osteocalcin. Updates in its physiological roles.

Authors:  Giovanni Lombardi; Silvia Perego; Livio Luzi; Giuseppe Banfi
Journal:  Endocrine       Date:  2014-08-27       Impact factor: 3.633

2.  Vitamin K and metabolic bone disease.

Authors:  C Vermeer; M H Knapen; L J Schurgers
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

Review 3.  Vitamin supplementation therapy in the elderly.

Authors:  J E Thurman; A D Mooradian
Journal:  Drugs Aging       Date:  1997-12       Impact factor: 3.923

4.  No effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women.

Authors:  L Rejnmark; P Vestergaard; P Charles; A P Hermann; C Brot; P Eiken; L Mosekilde
Journal:  Osteoporos Int       Date:  2006-05-09       Impact factor: 4.507

Review 5.  Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies.

Authors:  John A Batsis; Dennis T Villareal
Journal:  Nat Rev Endocrinol       Date:  2018-09       Impact factor: 43.330

Review 6.  Osteoporosis--a risk factor for cardiovascular disease?

Authors:  Christos E Lampropoulos; Ioanna Papaioannou; David P D'Cruz
Journal:  Nat Rev Rheumatol       Date:  2012-08-14       Impact factor: 20.543

Review 7.  Metabolic bone disease and parenteral nutrition.

Authors:  Cynthia Hamilton; Douglas L Seidner
Journal:  Curr Gastroenterol Rep       Date:  2004-08

Review 8.  Bone health. New role for vitamin K?

Authors:  Milly Ryan-Harshman; Walid Aldoori
Journal:  Can Fam Physician       Date:  2004-07       Impact factor: 3.275

9.  Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules.

Authors:  Tetsuo Inoue; Toshiharu Fujita; Hideaki Kishimoto; Toshitaka Makino; Tetsuro Nakamura; Toshitaka Nakamura; Tosiya Sato; Kaoru Yamazaki
Journal:  J Bone Miner Metab       Date:  2008-12-12       Impact factor: 2.626

10.  Prior treatment with vitamin K(2) significantly improves the efficacy of risedronate.

Authors:  Y Matsumoto; Y Mikuni-Takagaki; Y Kozai; K Miyagawa; K Naruse; H Wakao; R Kawamata; I Kashima; T Sakurai
Journal:  Osteoporos Int       Date:  2009-03-12       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.